IBTA e-News January 2019 now out

By 1st February 2019 February 28th, 2019 News archive
[31 January 2019] The IBTA's monthly e-News has been released and has emailed to all subscribers. To sign up to receive your copy, click here.

You can also read the IBTA e-News January 2019 edition in full online here.

Some of the highlights from this month's round-up:

  • New research has identified sex differences in glioblastoma, suggesting that tailoring treatments to men and women, based on the molecular subtypes of their tumours, may improve survival for all patients.
  • An article in the magazine Cancer World highlights recent advances in the molecular profiling of brain metastases by analysing circulating tumour cells (CTCs).
  • In a report published in Nature, researchers say they have shown that a personalized ‘neoantigen’ vaccine can spur a response against glioblastoma.
  • Australian researchers are developing a blood test which they hope will monitor brain tumours more accurately and allow doctors to assess whether they are stable or growing
  • Research published in the journal Clinical Cancer Research has found  B7-H3 is a promising target for CAR-T cell therapy in paediatric brain tumours.
  • A research team at the University of Oxford, UK, has launched a survey on clinical trial participation as part of an initiative called The Rare Cancer Project, which is seeking responses from people living in the UK living with a brain tumour. The survey aims to capture information about clinical trial enrolment from the perspective of patients, legal guardians and caregivers.
  • A Californian brain tumour patient who did not qualify as a clinical trial participant is set to become the first person to access an experimental treatment under the United States’ controversial Right to Try Act.
  • A systematic literature review shows that there is a small but growing body of neuro-oncology related research from Nigeria.

Our monthly e-News highlights items of interest to our international brain tumour community and is emailed to nearly 6,000 recipients. It gives a round-up of the latest research and treatment developments, news about brain tumour patient organisations around the world, and key forthcoming neuro-oncology scientific and patient conferences. You can sign up to receive the e-News every month by registering here.

To see an archive of existing e-News issues, click here.

let us know you agree to cookies

The IBTA website uses cookies to give you the best online experience in accordance with our cookies policy. If you are happy, please confirm by clicking the 'Accept' button below.